A detailed history of Nicholas Investment Partners, LP transactions in Axogen, Inc. stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 197,135 shares of AXGN stock, worth $2.93 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
197,135
Holding current value
$2.93 Million
% of portfolio
0.31%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$7.52 - $14.69 $1.48 Million - $2.9 Million
197,135 New
197,135 $2.76 Million
Q3 2018

Nov 14, 2018

SELL
$34.05 - $55.9 $2.63 Million - $4.31 Million
-77,173 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$36.15 - $52.5 $2.79 Million - $4.05 Million
77,173 New
77,173 $3.88 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $628M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.